We are building a personalized medicine company developing new therapeutics for unmet needs in the treatment of human cancers through use of our world-class predictive diagnostics platform.
Founded in 2004 in Denmark and publicly traded on NASDAQ First North (Stockholm).
Robust pipeline of 7 novel anti-cancer drugs
Robust Pipeline of 7 novel anti-cancer drugs that address significant cancer markets.
3 prioritized clinical programs
Best-in-class DRP® platform
Best-in-class DRP® platform creates drug-specific, predictive diagnostics to:
- Help select & treat the most likely responder patients for each of our pipeline drugs.
- Accelerate clinical development of each of our programs.
Strong intellectual property position
Strong intellectual property position with over 30 patents/applications in key world markets, covering DRP® diagnostics for more than 75 different cancer drugs.
Google Cloud interviews our Principal Infrastructure Engineer
A video by Google Cloud, explaining how Oncology Venture’s need of a high degree of performance, security and flexibility led to a partnership with Citrix and Google Cloud in order to ensure the best possible cloud solution for Oncology Venture.